BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen J, Ding J, Huang W, Sun L, Chen J, Liu Y, Zhan Q, Gao G, He X, Qiu G, Long P, Wei L, Lu Z, Sun Y. DNASE1L3 as a Novel Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma Based on Data Mining. Front Genet 2021;12:699242. [PMID: 34868195 DOI: 10.3389/fgene.2021.699242] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Meng F, Yang X, Xiao P. DNASE1L3 regulation by transcription factor FOXP2 affects the proliferation, migration, invasion and tube formation of lung adenocarcinoma. Exp Ther Med 2023;25:72. [PMID: 36684646 DOI: 10.3892/etm.2022.11771] [Reference Citation Analysis]
2 Ding P, Liu L, Bin Y, Huang Y, Chen L, Wen L, Zhang R, Tong F, Dong X. T Cell-Mediated Tumor Killing-Related Classification of the Immune Microenvironment and Prognosis Prediction of Lung Adenocarcinoma. J Clin Med 2022;11. [PMID: 36498802 DOI: 10.3390/jcm11237223] [Reference Citation Analysis]
3 Li B, Ge YZ, Yan WW, Gong B, Cao K, Zhao R, Li C, Zhang YW, Jiang YH, Zuo S. DNASE1L3 inhibits proliferation, invasion and metastasis of hepatocellular carcinoma by interacting with β-catenin to promote its ubiquitin degradation pathway. Cell Prolif 2022;:e13273. [PMID: 35748106 DOI: 10.1111/cpr.13273] [Reference Citation Analysis]
4 Chen Q, Yang S, Zhang Y, Li B, Xu H, Zuo S, Yang Z. Identification of MAD2L1 as a Potential Biomarker in Hepatocellular Carcinoma via Comprehensive Bioinformatics Analysis. BioMed Research International 2022;2022:1-12. [DOI: 10.1155/2022/9868022] [Reference Citation Analysis]